Quote:Fact Checkers Shred Paul Ryan For His False Claim That Every Taxpayer Will Get A Tax Cut
![]()
Ironic that this 'turkey' of a Bill 'needs' to be passed by thanksgiving.
Ain't going to happen.
Speaker of the House Paul Ryan was taken to task by fact checkers for claiming that every taxpayer will get a tax cut.
Video of Ryan making the false statement that every taxpayer will get a tax cut: https://www.youtube.com/watch?v=8xQCa9shNRw
After The Washington Post contacted Ryan’s office to point out that not every taxpayer would get a tax cut, the Speaker changed his language to the average person in every tax bracket will get a tax cut.
That doesn’t quite has the same heft, and it also doesn’t acknowledge the reality that at least 30% of taxpayers are going to see their taxes go up.
The Post let Ryan have it, “Still, on at least three occasions over three days, Ryan spoke in sweeping terms that flatly stated every taxpayer would get a tax cut. That’s wrong and misleading, and ordinarily worthy of Four Pinocchios.
Even if one assumes that all of the tax provisions remain in place — a big assumption — millions of Americans will still see a tax hike, even if the average person in their income range might receive a tax cut.
In the case of married families with children — whom Republicans are assiduously wooing as beneficiaries of their plan — about 40 percent are estimated to receive tax hikes by 2027, even if the provisions are retained. That would be a nasty surprise for folks who had heard Ryan’s less-precise spin.”
Ryan, Trump, and the rest of the GOP are lying about this tax cut plan. It is a bill that is designed to shift wealth to rich and corporations. It is not intended to help or assist middle or lower class people in any way. When a politician has to lie about what is in a bill, it is a bad bill.
There is no such thing as a free lunch. Every taxpayer is not going to get a tax cut. To pay for those tax cuts for the rich someone is going to have to pay more, and those who are going to be paying more are the taxpayers who can least afford it.
Ryan also plans to pay for his tax cuts by gutting Social Security and Medicare, so it is possible that not only will your taxes go up, but the social safety net could be gutted.
The truth is getting out, which is why the Republican lies are getting more extreme in their bid to sell a bad bill to millions of good people.
Fact Checkers Shred Paul Ryan For His False Claim That
Top 10 Most Recent News Articles
Elong Kicks Off Central Asia Strategy with Almaty Launch
Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...
Continue Reading
AptarGroup Faces Investigation: Shareholder Stakes High
AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...
Continue Reading
24X Partners with Standard Chartered for Crypto Leap
24X Steps Up the Game with Crypto Addition You gotta give it to 24X—they're not just twiddling their thumbs in the background. These folks in Bermuda have snagged another feather in their cap by expanding their partnership with heavyweight Standard Chartered, bringing Bitcoin and Ethereum into the mix. We're talking big moves here as 24X becomes the first to offer...
Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up
Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...
Continue Reading
Sino Biological Boosts AI Protein Discovery Efficiency
Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...
Continue Reading
VT Markets Unites Trading and Drama in New Finale
Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...
Continue Reading
Poland's Economic Boom: A Case for Freedom and Growth
Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...
Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward
Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...
Continue Reading
AION Labs Elevates Leadership, Eyes New R&D Horizons
Setting New Standards in Pharma Innovation The air in Rehovot, Israel might be filled with more than just technological aspirations, thanks to AION Labs stepping up its leadership game. This venture studio doesn't seem content to rest on its laurels. Nope, it's diving headlong into the deeper end of pharma R&D, scouting out fresh tech territories like quantum computing...
Continue Reading
1-800Accountant Secures Global Win in Tax Services
Another Feather in the Cap for 1-800Accountant You don’t get to be at the top of your game without turning a few heads. And 1-800Accountant has done just that, snagging the Fall 2026 Clutch Global Award for their expertise in the accounting universe. The Importance of Listening In this day and age, businesses large and small are realizing that the voice of the client is...
Continue ReadingTop 5 Most Recently Viewed Articles
Innovative Fundraising Campaign to Restore Food Bank Services
Transforming Community Support Through Art and Action In the wake of devastating wildfires that impacted a significant area, a new initiative is taking shape to assist those affected. This unique campaign combines the power of art and activism to address an urgent community need: the restoration of a food bank that has served countless families over the past two decades....
Continue Reading
OYO Expands Horizons with Acquisition of G6 Hospitality
OYO Acquires G6 Hospitality: A Major Strategic Move In a significant development, Oravel Stays, the parent company of OYO, has announced its acquisition of G6 Hospitality from Blackstone Real Estate for $525 million. This all-cash deal aims to strengthen OYO's presence in the U.S. hospitality industry. Growing Presence in the United States Since diving into the U.S....
Continue Reading
Dizal's Sunvozertinib Receives FDA Priority Review for NSCLC
FDA's Priority Review of Sunvozertinib: A Game Changer for NSCLC Dizal is making headlines with the announcement that the U.S. Food and Drug Administration (FDA) has granted priority review for the company's New Drug Application (NDA) for Sunvozertinib. This oral EGFR inhibitor holds the promise of offering a significant treatment option for patients suffering from...
Continue Reading
Deep Dive into Masimo Corporation's Ongoing Legal Troubles
Masimo Corporation Under Scrutiny Recently, the spotlight has turned to Masimo Corporation (NASDAQ: MASI) as investigations unfold regarding potential misconduct among its leadership. The inquiry is spearheaded by Charles C. Foti, Jr., a former Attorney General of Louisiana and partner at Kahn Swick & Foti, LLC. Revenue Shortfalls and Investor Concerns The company faced a...
Continue Reading
PMV Pharmaceuticals Unveils Promising Monotherapy Data for Solid Tumors
Exciting Developments in Cancer Treatment In the realm of precision oncology, PMV Pharmaceuticals continues to lead the charge with groundbreaking research that shines a spotlight on novel therapies. Today, the company has presented updated interim data that promises to reshape the treatment landscape for patients dealing with advanced solid tumors, particularly those...
Continue Reading